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An Amphotericin B-Ergosterol Covalent Conjugate
with Powerful Membrane Permeabilizing Activity
AmB and ergosterol/cholesterol, and, in particular, re-
garding the interaction between AmB and cholesterol in
biomembrane, negative experimental results have often
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Not only out of scientific interest but because of phar-Graduate School of Science
Osaka University macological importance, we became interested in the
mechanism underlying AmB-sterol and AmB-AmB inter-1-16 Machikaneyama
Toyonaka, Osaka 560-0043 actions in biomembrane; particularly, we have been fo-
cusing on the bimolecular interactions after AmB’s bind-2Innovative Nanotechnology Integration
JST ing to the membrane. For this purpose, we have
prepared several AmB conjugates and have demon-Senba-Higashi 2-4-14
Mino, Osaka 562-0035 strated in previous studies that covalently liked dimers
of AmB retain sterol selectivity similar to that of AmBJapan
[6–8]. In this study, we report the preparation of mem-
brane-active AmB-sterol conjugates and their mem-
brane permeabilizing activities determined by K fluxSummary
assays and channel current recording experiments.
Amphotericin B-sterol conjugates were synthesized
and examined for their membrane permeabilizing ac-
Results and Discussiontivity. Ergosterol and cholesterol, each connected with
amphotericin B via an ethylenecarbamate or hexa-
Preparation of AmB-Sterol Conjugatesmethylenecarbamate linker, were examined by K flux
According to molecular dynamics simulations carriedassays using liposomes and by single-channel re-
out for a barrel-stave model [1, 2] (Figure 1), 3-OH ofcording across phospholipid membrane. Among four
ergosterol presumably resides close to the mycosamineconjugates tested, AmB-ergosterol bearing an ethyl-
moiety of AmB [9]. Therefore, we attempted to connectenecarbamate linker exhibited the most powerful
the hydroxyl group of ergosterol/cholesterol with 3-NH2activity, which substantially exceeded that of the cho-
of AmB. This molecular design was expected to forcelesterol homolog. Single-channel recording clearly ex-
AmB and sterol parts to take a parallel position in closehibited that the ergosterol conjugate elicited channel
vicinity upon binding to membrane. Taking into consid-current with the conductance of 28 pS, which was
eration the chemical properties of functional groups [10,comparable with those by AmB, and revealed a higher
11], AmB and sterol were connected with an alkyl-carba-channel open probability than the cholesterol conju-
mate linker to provide conjugates 2–5 (Figure 2). Besidesgate. These results imply that direct interaction be-
feasibility in syntheses, these compounds were de-tween amphotericin B and ergosterol is reproduced
signed to retain the basic amino group in AmB, whichby their conjugate, which may serve as a model com-
was reportedly essential for membrane activity [12], andpound for understanding the drug’s selective toxicity.
to furnish a carbamate functionality attached to C3 of
the sterol part. This hydrogen-bonding group may facili-
Introduction tate the sterol moiety to take the upright position in
membrane, as reported by Regen et al. [13]. The syn-
Amphotericin B (AmB, 1) has been the drug of choice thetic route of these compounds was modified de-
for the treatment of systemic fungal infections for over pending on the length of linkers and ergosterol/choles-
40 years. Its antibiotic action is generally attributed to terol. For an ethylene-carbamate linker, the coupling
the higher affinity for ergosterol, principal fungal sterol, reaction between 3-amino-1,2-propanediol and sterol
than cholesterol occurring in mammalian membranes. carbonate followed by periodate oxidation provided the
Their structural differences are, however, rather minute: sterol-conjugated aldehyde, which was then subjected
in ergosterol, the presence of two additional carbon- to reductive aminoalkylation with the amino group of
carbon double bonds in ring B and a side chain that AmB to furnish conjugates 2 and 4 (Figure 3). For a
possesses one more methyl branching. This preference hexamethylene-carbamate linker, different routes were
of fungus sterol over human sterol is only 10-fold, which adopted for cholesterol and ergosterol, since unsuc-
is presumably responsible for serious side effects of the cessful oxidation of an alcohol in the presence of an
drug including nephrotoxicity and hypokalemia. Know- ergosterol moiety obliged us to do the aminoalkylation
ing the molecular interactions between AmB and sterol of AmB prior to formation of the carbamate linkage (see
[1, 2] is essential for establishing the structural basis of Experimental Procedures for details).
the drug’s toxicity in terms of both its medicinal virtues
and side effects. However, no experimental evidence
has been obtained for the direct interaction between UV Spectra of AmB-Sterol Conjugates
The interaction of the AmB conjugates in membrane was
first examined for their UV spectra using phospholipid*Correspondence: murata@ch.wani.osaka-u.ac.jp
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K influx into liposomes induces proton/K exchange in
the presence of proton-transporter FCCP, leading to a
rise in inner pH, which can be monitored by chemical
shift changes in 31P NMR. In the spectra of Figure 5A,
a downfield signal at  3.1 was derived from phosphate
entrapped in liposomes on which AmB formed ion-per-
meable channels and H leaked out at the expense of
K influx, while an upfield signal at  1.2 was due to
intact liposomes. In these experiments, AmB or AmB-
sterol conjugate was mixed with lipids prior to prepara-
tion of liposomes, since the conjugates could not be
suspended well and thus would hardly bind to liposome
membrane when added to a liposome-containing aque-
ous suspension. By using this procedure, the step of
Figure 1. Schematic Representation of Barrel-Stave Model for AmB AmB incorporation into membrane was skipped, and
Ion Channel
the formation of channel assemblages in membrane was
selectively observed. As shown in Figure 5A, AmB per-
liposomes. AmB-C2-Erg 2 showed smaller absorption meabilized ergosterol-containing membrane most effi-
maxima compared with those of AmB-C2-Cho 4 (Figure ciently while showing a low activity for cholesterol lipo-
4). These spectral differences can be accounted for by somes, even less efficacious than that for sterol-free
the stable complex formation with 2, where heptaene liposomes.
choromophores reside in close vicinity [14, 15]. In com- As shown in Figure 5A, AmB-C2-Erg 2 revealed theparison with the UV spectrum of AmB in cholesterol-
most powerful membrane permeabilizing activity for ste-
containing liposomes (data not shown; the absorbance
rol-free liposomes among the conjugates tested. In the
at 412 nm was 0.042), the absorption by AmB-C2-Cho 31P NMR spectrum of 2, a single peak was observed at
4 was markedly enhanced. These findings mean that
 3.1, which demonstrated that liposomes were mostly
the cholesterol part of 4 hampers formation of AmB
permeabilized. The efficacy of these conjugates shows
complex in membrane. A similar enhancement in UV
the tendency AmB-Erg  AmB  AmB-Cho, which is
spectra has been observed for AmB-phospholipid con-
parallel to the potency of AmB in sterol-containing mem-jugates [8, 18], which implies that a phospatidyl substitu-
brane. The concentration-activity relationship in Figureent on the amino group of AmB again decreases the
5B again reveals that AmB-C2-Erg 2 is much more effica-stability of AmB assemblages. Conversely, AmB-C2-Erg cious than AmB-C2-Cho 4 but somewhat less potent2, which also has a hydrophobic bulky substituent simi-
than AmB in ergosterol-containing liposomes. These re-lar to AmB-C2-Cho, showed contrasting results: the UV
sults imply that the specific recognition of ergosterol byabsorption at 412 nm was comparable with that of AmB
AmB is reproduced to a certain extent by AmB-C2-Ergin ergosterol-containing liposomes (data not shown; the
2, and also the tether between AmB and ergosterolabsorbance at 412 nm was 0.038). These results suggest
somewhat hampers their interaction. Nevertheless, thethat, unlike cholesterol or phospholipid conjugates, the
marked difference in the activity between 2 and 4 clearlyergosterol part in 2 does not prevent the complex forma-
indicates that minute differences in sterol structuretion but facilitates the self-assembly of AmB in associa-
greatly influence the molecular recognition by AmB.tion/dissociation equilibrium. The similar changes in UV
These observations may support the well-known hy-absorptions of AmB in ergosterol- or cholesterol-con-
pothesis that the antibiotic activity of AmB is attributedtaining liposomes have been reported for phospholipid
to its specific interaction with ergosterol upon formingmicelles [19].
an ion channel complex. A great number of experiments
previously carried out for AmB-sterol interactions mainlyMembrane Permeabilizing Activity
focused on their intermolecular recognition in mem-of AmB-Sterol Conjugates
brane, where clear distinction between direct interac-We next examined the membrane permeabilizing activ-
ity using a method reported by Gary-Bobo et al. [20, 21]. tions and indirect effects was sometimes difficult [16].
Figure 2. Structures of AmB-Sterol Conju-
gates (2–5)
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Figure 4. UV Spectra of Ergosterol-Conjugated AmB (2) and
Choresterol-Conjugated AmB (4)
The spectra of AmB-C2-Erg (2) (solid line) and AmB-C2-Cho (4)
(dashed line) were measured in liposomes consisting of egg phos-
phatidylcholine. Concentration of conjugate 2 or 4 was 1.4 M with
the ratio of conjugate/lipid (R ) of 3  104.Figure 3. Synthesis of AmB-C2-Erg (2) and AmB-C2-Cho (4)
The conjugated cholesterol part worked in a rather
inhibitory manner. This is the opposite of the generallyIn this study, the interaction is intramolecular, where
ergosterol always stays very close to AmB. Thus, the accepted idea. We have recently demonstrated that
cholesterol prevents ion channel formation by mem-enhanced membrane activity by AmB in ergosterol-con-
taining membrane should be ascribable to the direct brane-bound AmB using similar preparations of lipo-
somes [3]. The present results further support that cho-AmB-sterol interaction (not by indirect effects such as
membrane fluidity or ordering, as suggested for choles- lesterol does not participate in formation of a channel
complex [3, 4, 5, 23, 24].terol [22]).
Figure 5. Membrane Permeabilizing Activi-
ties of AmB (1) and AmB-Sterol Conjugates
(2 and 4)
(A) 31P NMR spectra of liposome-entrapped
phosphate for AmB (1) or AmB-sterol conju-
gates 2–5. AmB or conjugate was added to
lipids prior to liposome preparation and incu-
bated for 3 hr. Lipid concentration in a lipo-
some suspension was 12 mM. Liposomes
used for conjugates were composed only of
egg-phosphatidylcholine (PC), whereas 5%
ergosterol- or 20% cholesterol-containing PC
was also used for AmB. The peak around 
1.2 corresponds to H2PO4 at pH 5.5 (intact
liposomes) and that around  3.1 corresponds
to HPO42 at pH 7.5 (permeabilized lipo-
somes). Signals between  1.2 and 3.1 are
derived from liposomes with inside pH be-
tween 5.5 and 7.5. R, a molar ratio between
AmB or AmB conjugate and lipids, was 3 
104 for all the spectra.
(B) Concentration and activity relationship of
K flux activity for AmB (1), conjugates 2 and
4. Sterol-free liposomes were used for conju-
gates, whereas 5% ergosterol was contained
in the liposome for AmB. At higher concentra-
tions above R  103, the K flux activity
could not be determined because conjugates
2 and 4 were significantly lost due to absorp-
tion to a filter membrane during liposome
preparation. The y axis is a ratio of a peak area
at  3.1 out of the integration for  1.2–3.1.
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When comparing ergosterol conjugates with different
tether lengths, 2 with an ethylene linker showed signifi-
cantly stronger activity than 3 with a longer C6 linker
(Figure 5A); the same tendency can been seen for the
cholesterol conjugates 4 and 5. This difference in activity
may reflect the close proximity of C3-OH of sterol and
C3-NH2 of AmB in the channel complex, which is in
parallel with the molecular dynamics calculation by
Baran and Mazerski [9]. The observations further imply
the direct interaction between AmB and ergosterol,
probably through hydrogen bonding, near the mem-
brane surface of the channel complex.
Single-Channel Current Recording
and Antibiotic Assays
To investigate the behaviors of these sterol conjugates
at the level of single ion channels, we measured channel
currents by the tip-dip method. Figure 6A shows exam-
ples of current recordings for AmB, 2, and 4 at 150 mV
potential. In this experiment, diphytanoylphosphatidyl-
choline (DPhPC) was used as a membrane lipid, since
this phospholipid has good stability suitable for channel
recordings. DPhPC was also used for channel re-
cordings of AmB in the previous report [25], which facili-
tates the comparison of our results. Because of low
binding ability of conjugates to the membrane, AmB
or conjugate was premixed with membrane lipids, and
channel recordings were started after further addition
of the drug to the bath solution at a concentration of
3 M. Current fluctuations between open and closed
channel states were clearly observed for conjugates 2
and 4 in DPhPC as well as for AmB in ergosterol-DPhPC
(Figure 6A); particularly, formation of stable channels by
AmB can be seen in the presesnce of ergosterol, as
reported previously [25]. The ergosterol preference over
cholesterol in conjugates is seen in Figure 6B, where
AmB-C2-Erg 2 has higher channel open probability than Figure 6. Single-Channel Recording of AmB (1) and AmB-Sterol
AmB-C2-Cho 4. The average open probability of 2 in Conjugates (2 and 4)
DPhPC membrane is comparable with that of AmB in (A) Examples of current recordings of single channels induced by
AmB or AmB-sterol conjugate (2 or 4) with the tip-dip method atergosterol-DPhPC membrane (Figure 6B). The conduc-
150 mV applied potential. The aqueous solution contains 3 M KCl,tance of 2 was determined to be 28 pS (Figure 6C),
2.5 mM HEPES, and 1 mM CaCl2 (pH 7.4). Membrane conditionswhich is similar to or even higher than that of AmB,
are as follows: top, diphytanoylphosphatidylcholine (DPhPC), ergos-which is reported to be around 20 pS by Brutyan et al. terol, and AmB (molar ratio, 15000:3000:1); middle and bottom,
[25]. These findings from K ion-flux assays and ion DPhPC and AmB-C2-Erg (2) or AmB-C2-Cho (4) (molar ratio, 15000:1).
channel recordings indicate that properties and behav- Current recordings were started after further addition of AmB, 2, or
4 to the bath solution at a concentration of 3 M.iors of AmB-ergosterol conjugates in sterol-free mem-
(B) Average channel open probability at 150 mV for AmB (0.73 	brane are similar to those of AmB in ergosterol-con-
0.22, n  6), 2 (0.83 	 0.09, n  8), and 4 (0.27 	 0.10, n  5).taining phospholipid bilayers.
(C) Current/voltage relationship for AmB-C2-Erg (2). From a linearWe then attempted to evaluate the membrane per-
fit to the I/V relationship, the single-channel conductance of 2 was
meabilizing activity in biological systems. The sterol determined to be 28 pS.
conjugates 2–5 did not induce hemolysis up to 50 M
against 1% human erythrocytes, whereas AmB was ac-
ergosterol is stronger than that with cholesterol. Totive at 1.5 M. The conjugates did not reveal significant
our knowledge, this may be the first experimental evi-antifungal action even at 20 M against Candida albi-
dence that the direct interaction between amphoteri-cans and Paecilomyces varioti, where the EC50s of AmB
cin B and ergosterol in a lipid bilayer results in thewere around 0.1 M. These weak biological activities
marked enhancement of membrane permeabilizingmay be partly attributable to their poor solubility in wa-
activity. Some of the present conjugates, such aster, as seen for the K flux assays using liposomes.
AmB-C2-Erg 2, may possibly serve as models for in-
vestigating the precise mechanism of antibiotic actionSignificance
of AmB. Currently, we are attempting to prepare iso-
tope-labeled conjugates for solid-state NMR mea-In the present study, we have demonstrated that, in
membrane, the bimolecular interaction of AmB with surements. Interatomic distance estimated from the
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677
acetate [pH 5.3] changing linearly from 8:2 to 10:0 in 20 min). ESI-NMR data would help us elucidate the structure of a
MS m/z: 1445.5 (MH). 1H NMR (500 MHz, DMSO-d6:CDCl3  19:1):complicated molecular assemblage formed in mem-
 5.52 (dd, J  6, 2 Hz, 1H, 6″), 5.33 (m, 1H, 7″), 5.20 (m, 2H, 22″brane by AmB and sterol, which may provide invalu-
and 23″), 1.45-1.55 (m, 8H, 2″-5″). All other 1H NMR signals are
able information to reduce the drug’s side effects and practically identical with those of AmB-C2-Cho (4).
improve its pharmacological efficacy. N-(3-Cholesteryloxycarbonyloxy)succinimide (6)
This compound was obtained by a procedure similar to the one
applied for the preparation of N-(3-ergosteryl- oxycarbonyloxy)suc-Experimental Procedures
cinimide 6, starting from cholesterol (135 mg, 0.35 mol) instead of
ergosterol. Yield: 167 mg (90%); 1H NMR (500 MHz, CDCl3)  5.36Preparation of Amphotericin B-Sterol Conjugates
(d, 1H), 4. 54 (m, 1H), 2.78 (s, 4H), 0.98 (s, 3H), 0.87 (d, 3H), 0.82 (d,N-(3-Ergosteryloxycarbonyloxy)succinimide (6)
6H), 0.63 (s, 3H).Triethylamine (5 ml) was added to a stirred solution of ergosterol
N-(3-Cholesteryloxycarbony)-3-Amino-1,2-Propanediol (7)(1190 mg, 3.0 mmol) and N,N-disuccinimidyl carbonate (3300 mg,
A CH2Cl2 solution (2 ml) of N-(3-cholesteryloxycarbonyloxy)succini-13 mmol) in acetonitrile (50 ml). After being stirred at 23
C for 15 hr
mide 6 (103 mg, 195 mol) and 3-amino-1,2-propanediol (38 mg,under sonication, the mixture was diluted with aqueous saturated
417 mol) was stirred overnight at 23
C. Subsequently, the mixtureNaHCO3 (100 ml) and extracted with ethyl acetate. The organic layer
was concentrated under reduced pressure and purified by columnwas washed with brine and water, dried over anhydrous MgSO4,
chromatography on silica gel using hexane-ethyl acetate (1:1), pro-and concentrated in vacuo. Purification by column chromatography
viding N-(3-cholesteryloxycarbony)-3-amino-1,2-propanediol (95(SiO2) using hexane-ethyl acetate (3:1) as a mobile phase afforded
mg, 97%); 1H NMR (500 MHz, CDCl3)  5.36 (d, 1H), 4. 48 (m, 1H),N-(3-ergosteryloxycarbonyloxy)succinimide (1420 mg, 88%); 1H
3.74 (m, 1H), 3.57 (m, 2H), 3.31 (m 2H), 2.33 (dd, 1H), 2.26 (t, 1H),NMR (500 MHz, CDCl3)  5.54 (dd, 1H), 5.32 (m, 1H), 5.13 (m, 1H), 0.99 (s, 3H), 0.89 (d, 3H), 0.84 (d, 6H), 0.66 (s, 3H).5.12 (m, 1H), 4.64 (m, 1H), 2.77 (s, 4H), 2.61 (dd, 1H), 2.46 (t, 12 Hz,
N-(3-Cholesteryloxycarbony)aminoacetoaldehyde (8)1H), 0.97 (d, 3H), 0.90 (s, 3H), 0.85 (d, 3H), 0.76 (d, 6H), 0.56 (s, 3H).
This compound was obtained by a procedure similar to the oneN-(3-Ergosteryloxycarbonyl)-3-Amino-1,2-Propanediol (7)
used for the preparation of N-(3-ergosteryl- oxycarbonyl)aminoace-A mixture of N-(3-ergosteryloxycarbonyloxy)succinimide 6 (100 mg,
toaldehyde 8, starting from N-(3-cholesteryloxycarbony)-3-amino-
186 mol) and 3-amino-1,2-propanediol (56 mg, 615 mol) in CH2Cl2 1,2-propanediol 7 (95 mg, 189 mol). Yield: 64 mg (72%); 1H NMR
(5 ml) was stirred for 40 min at room temperature. Subsequently,
(500 MHz, CDCl3)  9.64 (s, 1H), 5.35 (d, 1H), 4.49 (m, 1H), 4.10 (m,the reaction mixture was mixed with saturated aqueous NH4Cl (10 2H), 2.34 (dd, 1H), 2.28 (t, 1H), 0.99 (s, 3H), 0.89 (d, 3H), 0.84 (d, 6H),
ml) and extracted with CHCl3. The organic layer was dried over 0.65 (s, 3H).
MgSO4 and concentrated in vacuo to furnish N-(3-ergosteryloxycar- AmB-C2-Cho (4)bonyl)-3-amino-1,2-propanediol (66 mg, 69%); 1H NMR (500 MHz,
This conjugate was obtained by a procedure analogous to that
CDCl3)  5.50 (dd, 1H), 5.31 (m, 1H), 5.15 (q, 1H), 5.11 (q, 1H), 4.53 described for AmB-C2-Erg (2). Reagent amounts: N-(3-cholesteryl-(m, 1H), 3.71 (m, 1H), 3.53 (m, 2H), 3.27 (m, 2H), 2.46 (dd, 1H), 2.27 oxycarbony)aminoacetoaldehyde (45 mg, 95 mol), AmB (120 mg,
(t, 1H), 0.97 (d, 3H), 0.88 (s, 3H), 0.85 (d, 3H), 0.76 (d, 6H), 0.56 (s, 3H). 130 mol), and NaBH3CN (38 mg, 578 mol). Yield: 46 mg (35%).N-(3-Ergosteryloxycarbonyl)aminoacetoaldehyde (8) HPLC retention time (YMC-ODS AM-323 10  250 mm): 41.8 min
To a solution of N-(3-ergosteryloxycarbonyl)-3-amino-1,2-pro- (flow rate, 1.5 ml/min; eluent, MeOH-5 mM ammonium acetate [pH
panediol 7 (54 mg, 105 mol) dissolved in THF (1 ml), 0.5 M aqueous 5.3] changing linearly from 8:2 to 10:0 in 20 min). ESI-MS m/z: 1379.6
NaIO4 (0.5 ml) was added. After being stirred vigorously for 1 hr, the (MH). 1H NMR signals (500 MHz) are listed in Table 1.
solution was treated with 1 M ethylene glycol (450 l) to reduce N-(3-Cholesteryloxycarbony)-6-Amino-1-Hexanol
excess NaIO4. The resulting solution was diluted with ethyl acetate, A mixture of N-(3-cholesteryloxycarbony)succinimide 6 (87 mg, 0.17
washed with water, and dried over MgSO4. Removal of solvent under mol) and 6-amino-1-hexanol (33 mg, 0.28mol) in CH2Cl2 (5 ml) was
reduced pressure gave N-(3-ergosteryloxycarbonyl)aminoacetoal- stirred overnight at room temperature. Subsequently, the reaction
dehyde (46 mg, 91%); 1H NMR (500 MHz, CDCl3)  9.60 (s, 1H), 5.50 mixture was diluted with ethyl acetate (10 ml) and washed with
(dd, 1H), 5.32 (dd, 1H), 5.13 (q, 1H), 5.11 (q, 1H), 4.08 (d, 2H), 2.47 saturated aqueous NH4Cl and distilled water. The organic layer was
(dd, 1H), 2.28 (t, 1H), 0.97 (d, 3H), 0.88 (s, 3H), 0.85 (d, 3H), 0.76 (d, dried over MgSO4 and evaporated under reduced pressure to yield
6H), 0.56 (s, 3H). N-(3-cholesteryl- oxycarbony)-6-amino-1-hexanol (85 mg, 97%); 1H
AmB-C2-Erg (2) NMR (500 MHz, CDCl3)  5.30 (dd, 1H), 4.54 (m, 1H), 4.42 (m, 1H),
A solution of N-(3-ergosteryloxycarbonyl)aminoacetoaldehyde 8 (8.5 3.57 (t, 2H), 3.10 (q, 2H), 2.29 (dd, 1H), 2.19 (t, 1H), 0.94 (s, 3H), 0.85
mg, 17mol) and AmB (17 mg, 18mol) in CHCl3-MeOH-H2O (10:6:1, (d, 3H), 0.80 (d, 6H), 0.61 (s, 3H).
1.5 ml) was stirred for 2 hr, and NaBH3CN (9 mg, 143 mol) was N-(3-Cholesteryloxycarbony)-6-Amino-1-Hexanal
added to the solution. After being stirred overnight, the solution was A CH2Cl2 (2 ml) solution of DMSO (160 l) was dropped into a stirred
diluted with CHCl3-MeOH (10:1, 10 ml) and washed with 1M HCl, solution of oxalyl chloride (160 l, 1.83 mol) in CH2Cl2 (2 ml) at
0.7% NH4OH, and then distilled water. The organic layer was con- 78
C. After 10 min at 78
C, a CH2Cl2 solution (5 ml) of N-(3-
centrated in vacuo and purified by column chromatography (SiO2, cholesteryl- oxycarbony)-6-amino-1-hexanol (463 mg, 0.87 mol)
CHCl3-MeOH-H2O 10:6:1) to afford AmB-C2-Erg (2) (5.3 mg, 22%). was slowly added to the solution, and the resulting mixture was
HPLC retention time (YMC-ODS AM-323 φ 10  250 mm): 44.7 min stirred at 78
C for 15 min and then at 45
C for 1 hr. The solution
(flow rate, 1.5 ml/min; eluent, MeOH-5 mM ammonium acetate [pH was treated with triethylamine (1 ml) and stirred for 20 min at 0
C.
5.3] changing linearly from 8:2 to 10:0 in 20 min). ESI-MS m/z: 1389.5 The reaction was quenched with saturated aqueous NH4Cl (10 ml)
(MH). 1H NMR (500 MHz, DMSO-d6:CDCl3  19:1):  5.52 (dd, J  and extracted with ethyl acetate. The organic layer was dried over
6, 2 Hz, 1H, 6″), 5.33 (m, 1H, 7″), 5.20 (m, 2H, 22″ and 23″). All MgSO4 and concentrated under reduced pressure. Column chroma-
other 1H NMR signals are practically identical with those of AmB- tography on silica gel (hexane: EtOAc 3:1) provided N-(3-cholesteryl-
C2-Cho (4) described below. oxycarbony)- 6-amino-1-hexanal (281 mg, 61%); 1H NMR (500 MHz,
AmB-C6-Erg (3) CDCl3)  9.74 (t, 1H), 5.35 (dd, 1H), 4.58 (m, 1H), 4.46 (m, 1H), 3.14
To a DMSO solution (1 ml) of ergosterol (48 mg, 90 mol) and N-6- (q, 2H), 2.42 (dt, 2H), 2.34 (dd, 1H), 2.24 (t, 1H), 0.98 (s, 3H), 0.89 (d,
aminohexyl-amphotericin B (56 mg, 55 mol), which was prepared 3H), 0.84 (d, 6H), 0.65 (s, 3H).
by following the same procedure as described previously [6], trieth- AmB-C6-Cho (5)
ylamine (50 l) was added. After being stirred overnight at room A solution of N-(3-cholesteryloxycarbony)-6-amino-1-hexanal (10
temperature, a yellow precipitate was formed by addition of diethyl mg, 19 mol) and AmB (20 mg, 22 mol) in CHCl3-MeOH-water
ether to the solution. The precipitate was isolated on Celite, washed (10:6:1, 3 ml) was stirred for 2 hr, and NaBH3CN (30 mg, 0.48 mmol)
with diethyl ether, and purified by column chromatography (SiO2, was added to the solution. After 15 hr, diethyl ether was added to
CHCl3-MeOH-water 10:6:1) to give AmB-C6-Erg (3) (15 mg, 18%). form a yellowish precipitate. The precipitate was collected on Celite
HPLC retention time (YMC-ODS AM-323 φ 10x250 mm): 44.7 min and washed with diethyl ether. Purification was achieved by MPLC
(gel: YMC ODS-AQ120-S50) eluting with MeOH-5 mM ammonium(flow rate, 1.5 ml/min; eluent, 1.5 ml of MeOH-5 mM ammonium
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Table 1. 1H NMR Chemical Shifts for AmB-C2-Cho (4) in DMSO-d6:CDCl3  19:1
Position  Position  Position 
2 2.21 32 6.08 6 1.18
3 4.06 33 5.44 1″ 2.52, 2.70
4 1.43 34 2.32 2″ 3.08
5 3.58 35 3.13 2 1.79
10 1.60 36 1.77 3 4.33
11 4.23 37 5.21 4 2.28
14 1.93, 1.12 38 1.12 6 5.33
15 4.04 40 1.04 7 1.93
16 2.02 41 0.92 18 0.64
17 4.23 1 4.35 19 0.97
18 2.02 2 3.80 20 1.38
19 4.41 3 2.80 21 0.90
20 6.00 4 3.19 25 1.51
21–31 6.0–6.5 5 3.19 26, 27 0.85
acetate buffer (pH 5.3) (linear gradient from 8:2 to 10:0 in 20 min) to molar ratios. The incubation time was 6 hr. Sterol-free liposomes
were used for the conjugates 2 and 4, whereas 5% ergosterol wasfurnish AmB-C6-Cho (5) (5.7 mg, 21%). HPLC retention time (column:
YMC-ODS AM-323 φ 10x250 mm): 53.2 min (flow rate, 1.5 ml/min; contained in the liposomes for AmB. At higher concentration above
R  103, the K flux activity could not be determined because theeluent, MeOH-5 mM ammonium acetate [pH 5.3] changing linearly
from 8:2 to 10:0 in 20 min). ESI-MS m/z: 1435.6 (MH). 1H NMR conjugates 2 and 4 were significantly lost due to absorption to a
filter membrane during liposome preparation. The y axis is a ratio(500 MHz, DMSO-d6:CDCl3  19:1):  1.45-1.55 (m, 8H, 2″-5″). All
other 1H NMR signals are identical with those of AmB-C2-Cho (4). of a peak area at  3.1 out of the integration for  1.2–3.1.
Liposome Preparation
UV Spectra
Large unilamellar vesicles (LUV) were prepared according to meth-
For the UV spectral measurements, LUV was prepared by the same
ods reported by Herve et al. [17]. Briefly, 72 mol of egg phosphati-
method described above except for using 9% sucrose solution; at
dylcholine and the corresponding amount of AmB or AmB conjugate
low AmB-lipid ratios (R ) below 0.001, phosphate buffer caused light
were dissolved in 1 ml of MeOH-CHCl3, and the mixture was evapo- scattering. Concentration of conjugate 2 or 4 was 1.4 M with the
rated to a thin film in a round-bottom flask. In the case of 5%
ratio of conjugate/lipid (R ) of 3  104.
ergosterol-containing LUV, 5 mol% of egg phosphatidylcholine was
replaced with ergosterol. After drying in vacuo for over 8 hr, 1 ml
of pH 5.5 buffer containing 0.4 mM KH2PO4 and 1mM EDTA in H2O- Channel Current Recording
Single-channel recordings from lipid bilayers were obtained usingD2O 6:4 was added to the flask. The lipid mixture was suspended
in the buffer by vortexing and sonication. The resultant suspension the tip-dip method. In brief, patch-clamp pipettes (Harvard GC-
150T-10) were made using a P97 Sutter Instruments puller (Novato,was frozen at 20
C and thawed at 60
C three times. The LUV
suspension was diluted with 5 ml of 0.4 mM K2SO4 and mixed with 9.7 CA) to have a tip diameter of 10 m. The same solution was used
both in the bath and in the pipette (3 M KCl, 2.5 mM HEPES, 1 mMl of 1 mM carbonyl cyanide-p-trifluoromethoxyphenyl hydrazone
(FCCP) in ethanol. The LUV thus obtained was passed repeatedly CaCl2, pH 7.4). Monolayer was formed by spreading n-hexane solu-
tions of mixed lipids on the surface of the bath. The pipette tip,through a membrane filter (pore size 0.2m, 19 times) with a Liposo-
fast apparatus (AVESTIN). We checked the retention rate of 2 and precoated with hexadecane, was repeatedly passed through the
surface of the solution until the pipette resistance rose above 54 after the process for liposome formation, and more than 90% of
the drug was retained in the liposome membrane at the sample/ gigaohms. In this study, three kinds of premixed lipids were used: (1)
diphytanoylphosphatidylcholine (DPhPC, Avanti Polar Lipids, Inc.),lipid ratio below 103.
ergosterol, and AmB (15000:3000:1 in molar ratio) for AmB single-
channel recording; (2) DPhPC and 2 (15000:1 in molar ratio) forK Flux Assays Using 31P NMR
For K flux assays, an LUV suspension was adjusted to pH 7.5 recording of AmB-ergosterol conjugate; and (3) DPhPC and 4
(15000:1 in molar ratio) for AmB-cholesterol conjugate. AmB, 2, orwith KOH. After 3 hr at 23
C, 550 l of the LUV suspension (lipid
concentration was 12 mM) was transferred to a 5-mm NMR glass 4 was further added to the bath at the concentration of 3 M prior
to channel recordings. A patch-clamp amplifier CEZ-2400 (Nihon-tube and mixed with 4.4 l of 100 mM MnCl2. 31P NMR spectrum
was recorded at 23
C on a JEOL GSX-500 spectrometer (31P at Kohden, Japan) was used to record single-channel currents. The
applied potential was 150 mV. Current recordings were digitized at202.35 MHz) with 1H-broad band decoupling. The assay was gener-
ally repeated more than three times for each sample with good 5 kHz and filtered at 1 kHz. Single-channel analyses were carried
out using the commercial software pClamp 9 (Axon Instruments,reproducibility. The concentration-activity relationship shown in Fig-
ure 5B was depicted by making liposomes with various sample/lipid Novato, CA).
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